Literature DB >> 14564191

Transradial approach for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: comparison with conventional transfemoral approach.

Shunichi Shiozawa1, Akira Tsuchiya, Shungo Endo, Hiroyuki Kato, Takao Katsube, Kenichi Kumazawa, Yoshihiko Naritaka, Kenji Ogawa.   

Abstract

We evaluated the clinical usefulness and safety of transradial approach for transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) compared with that of conventional transfemoral approach. The two groups (radial group, n = 177; femoral group, n = 150) of cases were retrospectively compared with regard to the successful rate of angiography or TACE, time required for catheterizaiton and complications. Hepatic angiography and TACE were completed in 174 (98.3%) of 177 cases in the radial group. There was no intergroup difference of time required for catheterization. Minor complications (dull pain, numbness) occurred in 8 (4.6%) patients in the radial group, and there were lower complications in the radial group compared to the femoral group. TACE by our new transradial approach was found to have therapeutic efficacy with lower complications comparable to that of the conventional transfemoral approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564191     DOI: 10.1097/00004836-200311000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  9 in total

1.  Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access.

Authors:  Bela Kis; Matthew Mills; Sarah E Hoffe
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

2.  Outpatient Transradial Emborrhoid Technique: A Pilot Study.

Authors:  Roberto Iezzi; Paola Campenni; Alessandro Posa; Angelo Parello; Elena Rodolfino; Angelo Alessandro Marra; Carlo Ratto; Riccardo Manfredi
Journal:  Cardiovasc Intervent Radiol       Date:  2021-05-11       Impact factor: 2.740

3.  A reality check in transradial access: a single-centre comparison of transradial and transfemoral access for abdominal and peripheral intervention.

Authors:  Matthew L Hung; Edward W Lee; Justin P McWilliams; Siddharth A Padia; Pengxu Ding; Stephen T Kee
Journal:  Eur Radiol       Date:  2018-06-20       Impact factor: 5.315

4.  Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma.

Authors:  Abheek Ghosh; Jian Zhang; Nabeel Mohsin Akhter
Journal:  J Clin Imaging Sci       Date:  2022-05-12

Review 5.  Update on Transradial Access for Percutaneous Transcatheter Visceral Artery Embolization.

Authors:  Hee Ho Chu; Jong Woo Kim; Ji Hoon Shin; Soo Buem Cho
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

6.  Prostatic Artery Embolization for Lower Urinary Tract Symptoms via Transradial Versus Transfemoral Artery Access: Single-Center Technical Outcomes.

Authors:  Ryun Gil; Dong Jae Shim; Doyoung Kim; Dong Hwan Lee; Jung Jun Kim; Jung Whee Lee
Journal:  Korean J Radiol       Date:  2022-05       Impact factor: 3.500

7.  A Novel Thoracoabdominal Aorta CTA-based Nomogram Model to Identify Ideal Candidates for Transradial Approach Chemoembolization in Patients with Liver Cancer.

Authors:  Miao Li; Feng Zhang; Shen-Xin Lu; Yan Shan; Peng-Ju Xu; Ying-Ting Zhou; Ying-E Zhu; Zheng-Gang Ren; Bi-Wei Yang; Xin Yin
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

8.  Transradial vs transfemoral access in patients with hepatic malignancy and undergoing hepatic interventions: A systematic review and meta-analysis.

Authors:  Yuan-Yuan Chen; Pan Liu; Yu-Shen Wu; Huapeng Lin; Xiaopin Chen
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

9.  Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access.

Authors:  Nan Du; Min-Jie Yang; Jing-Qin Ma; Jian-Jun Luo; Zi-Han Zhang; Tian-Zhu Yu; Zhi-Yuan Zheng; Wen Zhang; Zhi-Ping Yan
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.